Clover Health’s 2026 Medicare Advantage Plans Champion Affordability and Choice
Clover Health (Nasdaq: CLOV) announced its 2026 Medicare Advantage portfolio, preserving a comprehensive PPO lineup with $0 to low monthly premiums and Part B givebacks as Annual Enrollment Period opens Oct 15–Dec 7, 2025. The company says 100% of members will have stable or improved 2026 benefits and plans will be accessible to 5.2 million Medicare-eligible beneficiaries across 203 counties in 5 states. Clover credits its AI-powered Clover Assistant with earlier interventions—doctors start diabetes oral meds ~3 years earlier and diagnose CKD ~1.5 years earlier—and reports 32% YoY MA member growth.
Clover Health (Nasdaq: CLOV) ha annunciato il suo portafoglio Medicare Advantage 2026, mantenendo una completa lineup PPO con $0 a premi mensili bassi e rimborsi del Part B mentre si apre il Periodo di Enrollamento Annuale 15 ottobre–7 dicembre 2025. L’azienda afferma che il 100% dei membri avrà benefici stabili o migliorati nel 2026 e i piani saranno accessibili a 5,2 milioni di beneficiari idonei a Medicare in 203 contee in 5 stati. Clover attribuisce al suo Clover Assistant, alimentato dall’IA, interventi precoci—i medici iniziano i farmaci orali per il diabete circa 3 anni prima e diagnosticano CKD circa 1,5 anni prima—e riporta una crescita dei membri MA su base annua pari al 32%.
Clover Health (Nasdaq: CLOV) anunció su cartera de Medicare Advantage 2026, manteniendo una completa oferta PPO con $0 a primas mensuales bajas y devoluciones del Parte B cuando se abre el Período de Inscripción Anual 15 de octubre al 7 de diciembre de 2025. La empresa afirma que el 100% de los miembros tendrá beneficios estables o mejorados en 2026 y los planes serán accesibles para 5,2 millones de beneficiarios elegibles para Medicare en 203 condados de 5 estados. Clover atribuye a su Clover Assistant, impulsado por IA, intervenciones más tempranas—los médicos comienzan los medicamentos orales para la diabetes aproximadamente 3 años antes y diagnostican CKD aproximadamente 1,5 años antes—y reporta un crecimiento interanual de MA de 32%.
Clover Health (Nasdaq: CLOV) 는 메디케어 어드밴티지 2026 포트폴리오를 발표하며 $0에서 낮은 월 보험료와 Part B 환급을 유지하고 연간 등록 기간이 2025년 10월 15일~12월 7일에 열립니다. 회사는 2026년 혜택이 100%의 구성원에게 안정적이거나 개선될 것이며 계획은 5.2백만의 Medicare 자격 수혜자에게 5개 주의 203개 카운티에서 제공될 것이라고 말합니다. Clover는 AI 기반의 Clover Assistant의 조기 개입 덕분에 의사들이 당뇨 구강 약물을 약 3년 더 빨리 시작하고 CKD를 약 1.5년 빨리 진단한다고 하며 전년 대비 MA 멤버 성장률 32%를 보고합니다.
Clover Health (Nasdaq : CLOV) a annoncé son portefeuille Medicare Advantage 2026, préservant une offre PPO complète avec $0 à faible primes mensuelles et des remboursements Part B alors que la période annuelle d’inscription s’ouvre du 15 octobre au 7 décembre 2025. L’entreprise indique que 100% des membres auront des prestations stabilisées ou améliorées en 2026 et que les plans seront accessibles à 5,2 millions de bénéficiaires éligibles à Medicare dans 203 comtés dans 5 États. Clover attribue à son assistant IA Clover Assistant des interventions plus précoces — les médecins commencent les médicaments oraux pour le diabète environ 3 ans plus tôt et diagnostiquent CKD environ 1,5 ans plus tôt — et rapporte une croissance annuelle des membres MA de 32%.
Clover Health (Nasdaq: CLOV) kündigte sein 2026 Medicare Advantage-Portfolio an und bewahrt eine umfassende PPO-Auswahl mit $0 bis zu niedrigen monatlichen Prämien und Part-B-Rückerstattungen, während das Open Enrollment Period vom 15. Oktober bis 7. Dezember 2025 beginnt. Das Unternehmen sagt, dass 100% der Mitglieder stabile oder verbesserte Leistungen im Jahr 2026 haben werden und dass Pläne für 5,2 Millionen Medicare-berechtigte Begünstigte in 203 Landkreis in 5 Bundesstaaten zugänglich sein werden. Clover schreibt seinem KI-basierten Clover Assistant frühere Interventionen zu — Ärzte beginnen Diabetes-Oralmedikationen ca. 3 Jahre früher und diagnostizieren CKD ca. 1,5 Jahre früher — und meldet ein 32% YoY MA-Mitgliederwachstum.
Clover Health (ناسداك: CLOV) أعلنت عن محفظة Medicare Advantage 2026، مع الحفاظ على تشكيلة PPO شاملة مع $0 إلى أقساط شهرية منخفضة وعمليات استرداد جزء B بينما يفتح فترة التسجيل السنوية 15 أكتوبر–7 ديسمبر 2025. تقول الشركة إن 100% من الأعضاء سيكون لديهم مزايا ثابتة أو محسّنة في 2026 وأن الخطط ستكون متاحة لـ 5.2 مليون مستفيد مؤهل لـ Medicare عبر 203 مقاطعات في 5 ولايات. تعزو Clover لإسهام مساعدها المعزز بالذكاء الاصطناعي Clover Assistant تدخلات مبكرة — يبدأ الأطباء أدوية السكري الفموية نحو 3 سنوات مبكرًا ويشخّصون CKD نحو 1.5 سنة مبكرًا — وتذكر نمو أعضاء MA بنسبة 32% على أساس سنوي.
Clover Health (Nasdaq: CLOV) 宣布其 2026 年 Medicare Advantage 产品组合，保留全面的 PPO 阵容，提供 $0 至低额月保费 和 Part B 返还，年度注册期在 2025 年 10 月 15 日至 12 月 7 日 开放。公司表示，2026 年的福利对 100% 的成员而言将保持稳定或改善，计划将面向 5.2 百万 Medicare 合格受益人，在 5 个州的 203 个县 可访问。Clover 将其 AI 支持的 Clover Assistant 归因于更早的干预——医生大约在 3 年前 开始口服糖尿病药物，约在 1.5 年前 诊断 CKD——并报告 同比 32% 的 MA 会员增长。
- 32% YoY growth in Medicare Advantage members
- 100% of members to have stable or improved 2026 benefits
- Plans accessible to 5.2M Medicare-eligible beneficiaries in 203 counties
- $0 to low monthly premium PPO and Part B giveback options
- Geographic footprint limited to 5 states, constraining national scale
- Material reliance on Clover Assistant AI for clinical improvements
Insights
Clover’s 2026 MA portfolio strengthens affordability and reach, supported by AI-driven clinical claims and member growth.
Clover Health preserves broad PPO choice while offering
The business mechanism rests on member acquisition and retention through competitive benefit design and clinician-facing AI that the company says accelerates diabetes and CKD intervention. Key dependencies include continued efficacy of the Clover Assistant data signals and operational delivery of extra benefits and care services. Watch the
The Company Reinforces Market Position, Maintaining Comprehensive PPO Portfolio As Clover Assistant Drives Sustainable Value
JERSEY CITY, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company dedicated to bringing access to great healthcare to everyone on Medicare, today announced its 2026 Medicare Advantage offerings, reinforcing Clover’s leadership in affordable, high-choice PPO plans that deliver real results for seniors and physicians alike as the Annual Enrollment Period opens.
While the industry shifts toward narrower HMO networks, Clover continues to offer a robust portfolio of PPO plans featuring
"Many seniors are now navigating a landscape of fewer plan choices and rising costs. Our 2026 offerings are a direct reflection of our unwavering commitment to put their needs first," said Jamie Reynoso, CEO of Medicare Advantage at Clover Health. "By preserving our PPO plans and enhancing our benefits, we are ensuring our members have the stability, choice predictability, and value they deserve, especially when others are pulling back."
Clover Health Medicare Advantage Plans maintain four key principles:
- Affordability: Plans offer a wide range of
$0 t o low monthly plan premium MAPD plans, including options that pair well with the federal Extra Help program. - Flexibility: Members enjoy open access to a large network of hospitals and providers with no referrals required to see specialists.
- Predictability: Clover Health plans are designed with a focus on simple copays rather than complex coinsurance, allowing members to better anticipate their healthcare expenses.
- Value: Every plan is built to support whole-person health, providing meaningful extra benefits at no additional cost including fitness, dental, vision, and hearing. All members are also eligible for the LiveHealthy Rewards program. In addition, Clover offers direct support to members via its Clover Care Services arm, which includes welcome-home visits for members coming out of acute care facilities, an active cancer support program, and direct-to-home hospice and palliative care support services for members with acute illness.
Clover’s ability to maintain and enhance benefits is underpinned by the AI-powered Clover Assistant platform that aggregates patient data across the healthcare ecosystem to support clinical decision-making and improve health outcomes through early identification and management of chronic disease. For example, data shows that doctors empowered with Clover Assistant start their diabetes patients on oral medications three years earlier on average. Earlier intervention has been associated with reduced reliance on insulin and lower incidence of hypoglycemia. Similarly, doctors empowered with Clover Assistant diagnose and manage chronic kidney disease over 1.5 years earlier. This earlier intervention has been associated with decelerating decline of kidney function for CKD patients. This model has contributed to Clover’s sustainable
The 2026 Annual Enrollment Period runs from October 15 to December 7, 2025. Clover Health plans will be accessible by 5.2 million Medicare-eligible beneficiaries in 2026, within 203 counties across 5 states. Plans available based on location are available to view here.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, Congestive Heart Failure, and Chronic Obstructive Pulmonary Disease as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Visit: www.cloverhealth.com
Investor Relations:
Ryan Schmidt
Press Inquiries:
Clover Health is a Preferred Provider Organization (PPO) and a Health Maintenance Organization (HMO) with a Medicare contract. Enrollment in Clover Health depends on contract renewal.
Y0129_25EX130_C
FAQ
What Medicare Advantage plans did Clover Health (CLOV) announce for 2026?
How many beneficiaries will Clover Health plans reach in 2026 and where?
When is Clover Health’s 2026 Annual Enrollment Period for CLOV plans?
What clinical benefits does Clover cite from its Clover Assistant platform?
What does Clover’s 32% YoY MA member growth mean for CLOV shareholders?
Do Clover Health 2026 plans maintain provider choice for members?
